CSIMarket Company Name, Ticker, Competitors, else..
 
Adverum Biotechnologies Inc   (NASDAQ: ADVM)
Other Ticker:  
 
 

ADVM's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2025-06-14T21:33:38+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Adverum Biotechnologies Inc 1.60 0.00% 0.00 % 0.00 %
Amgen Inc 33,424.00 65.71% 66.79% 65.32%
Biogen Inc 9,816.40 19.30% 17.87% 18.86%
Exelixis Inc 2,298.92 4.52% 4.08% 4.35%
Sarepta Therapeutics Inc 2,233.37 4.39% 5.48% 5.06%
Halozyme Therapeutics Inc 1,084.31 2.13% 1.95% 2.29%
Mirum Pharmaceuticals Inc 379.25 0.75% 0.82% 0.76%
Immunocore Holdings Plc 333.58 0.66% 0.69% 0.65%
Atara Biotherapeutics Inc 303.06 0.60% 0.72% 0.73%
Xeris Biopharma Holdings Inc 222.55 0.44% 0.44% 0.46%
Coherus Biosciences inc 197.50 0.39% 0.06% 0.42%
Regenxbio Inc 156.72 0.31% 0.65% 0.16%
Denali Therapeutics Inc 110.69 0.22% 0.00% 0.00%
Bluebird Bio Inc 103.95 0.20% 0.28% 0.30%
Alector Inc 88.34 0.17% 0.03% 0.42%
Inventiva S a 45.52 0.09% 0.09% 0.00%
Meiragtx Holdings Plc 34.51 0.07% 0.01% 0.16%
Liquidia Corporation 14.14 0.03% 0.02% 0.02%
Novabay Pharmaceuticals Inc 9.48 0.02% 0.00% 0.02%
Ocugen Inc 4.52 0.01% 0.01% 0.01%
Hoth Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Aura Biosciences Inc 0.00 0.00% 0.00% 0.00%
Protara Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Biomx Inc 0.00 0.00% 0.00% 0.00%
Genenta Science S p a 0.00 0.00% 0.00% 0.00%
Lexeo Therapeutics Inc 0.00 0.00% 0.00% 0.00%
SUBTOTAL 50,862.41 100% 13,603.04 100%



ADVM's Market share relative to its competitors, as of Q1 2025 within the Biotechnology & Pharmaceuticals Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Adverum Biotechnologies Inc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 69.69% 69.74% 71.70% 69.75%
Biogen Inc 20.47% 20.74% 19.18% 20.13%
Exelixis Inc 4.79% 4.65% 4.38% 4.65%
Halozyme Therapeutics Inc 2.26% 2.18% 2.09% 2.44%
Immunocore Holdings Plc 0.70% 0.66% 0.74% 0.69%
Atara Biotherapeutics Inc 0.63% 0.56% 0.78% 0.78%
Coherus Biosciences inc 0.41% 0.57% 0.06% 0.44%
Regenxbio Inc 0.33% 0.18% 0.70% 0.17%
Denali Therapeutics Inc 0.23% 0.24% 0.00% 0.00%
Bluebird Bio Inc 0.22% 0.18% 0.31% 0.32%
Alector Inc 0.18% 0.22% 0.03% 0.44%
Meiragtx Holdings Plc 0.07% 0.07% 0.02% 0.18%
Ocugen Inc 0.01% 0.01% 0.01% 0.01%
Aura Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Protara Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Biomx Inc 0.00% 0.00% 0.00% 0.00%
Genenta Science S p a 0.00% 0.00% 0.00% 0.00%
Lexeo Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



ADVM's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Adverum Biotechnologies Inc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 65.71% 66.22% 66.79% 65.32%
Biogen Inc 19.30% 19.69% 17.87% 18.86%
Exelixis Inc 4.52% 4.41% 4.08% 4.35%
Sarepta Therapeutics Inc 4.39% 3.87% 5.48% 5.06%
Halozyme Therapeutics Inc 2.13% 2.07% 1.95% 2.29%
Mirum Pharmaceuticals Inc 0.75% 0.69% 0.82% 0.76%
Immunocore Holdings Plc 0.66% 0.63% 0.69% 0.65%
Atara Biotherapeutics Inc 0.60% 0.53% 0.72% 0.73%
Xeris Biopharma Holdings Inc 0.44% 0.41% 0.44% 0.46%
Coherus Biosciences inc 0.39% 0.54% 0.06% 0.42%
Regenxbio Inc 0.31% 0.17% 0.65% 0.16%
Denali Therapeutics Inc 0.22% 0.23% 0.00% 0.00%
Bluebird Bio Inc 0.20% 0.17% 0.28% 0.30%
Alector Inc 0.17% 0.20% 0.03% 0.42%
Inventiva S a 0.09% 0.03% 0.09% 0.03%
Meiragtx Holdings Plc 0.07% 0.07% 0.01% 0.16%
Liquidia Corporation 0.03% 0.03% 0.02% 0.02%
Novabay Pharmaceuticals Inc 0.02% 0.02% 0.00% 0.02%
Ocugen Inc 0.01% 0.01% 0.01% 0.01%
Hoth Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Aura Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Protara Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Biomx Inc 0.00% 0.00% 0.00% 0.00%
Genenta Science S p a 0.00% 0.00% 0.00% 0.00%
Lexeo Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Adverum Biotechnologies Inc's market divisions, geographic dispersion, segments, products, and services, visit Adverum Biotechnologies Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com